Background: Recurrent Clostridium difficile infection is common and difficult to manage. It returns in approximately 20% to 30% of cases after a first episode and more frequently after recurrent episodes (1). Because of the high rate of recurrence, many treatment alternatives have been proposed, especially metronidazole or vancomycin (including pulsed or tapered vancomycin); however, these therapies are often unsuccessful (1, 2). Disrupted fecal microbiota from previous antibiotics play a major role in recurrent C. difficile infection, and fecal microbiota therapy works by restoring the recipient's natural microbiota (1). The procedure includes testing the donor for infections that could be transmitted ...

References

  • 1. Gough E Shaikh H , and  Manges AR Systematic review of intestinal microbiota transplantation (fecal bacteriotherapy) for recurrent Clostridium difficile infection. Clin Infect Dis2011;53:994-1002. [PMID: 22002980] CrossrefGoogle Scholar
  • 2. Aas J Gessert CE , and  Bakken JS Recurrent Clostridium difficile colitis: case series involving 18 patients treated with donor stool administered via a nasogastric tube. Clin Infect Dis2003;36:580-5. [PMID: 12594638] CrossrefGoogle Scholar
  • 3. van Nood E Vrieze A Nieuwdorp M Fuentes S Zoetendal EG de Vos WM et alDuodenal infusion of donor feces for recurrent Clostridium difficile. N Engl J Med2013;368:407-15. [PMID: 23323867] CrossrefGoogle Scholar
  • 4. Neemann K Eichele DD Smith PW Bociek R Akhtari M , and  Freifeld A Fecal microbiota transplantation for fulminant Clostridium difficile infection in an allogeneic stem cell transplant patient. Transpl Infect Dis2012;14:161-5. [PMID: 23121625] CrossrefGoogle Scholar
  • 5. Sivapalasingam S  and  Blaser MJ Bacterial diarrhea in HIV-infected patients: why Clostridium difficile, and why now? [Editorial]. Clin Infect Dis2005;41:1628-30. [PMID: 16267736] CrossrefGoogle Scholar